The GM pet industry continues apace–a California-based company has started taking orders for genetically modified cats, altered to ease the sufferings of humans who have pet allergies.
Allerca is selling the cats for $3,500 each, to be delivered starting in 2007. Up to 10 percent of the U.S. population has allergies to cats, and according to CNN, cat allergen is also one of the main causes of childhood allergies, asthma, and other respiratory diseases such as bronchitis. Allerca suppresses production of a protein secreted by the cat’s skin and salivary glands that cause cat allergies.
I expect little uproar about these cats, just as there was little long-lasting concern about GloFish, which have gone on sale in pet stores earlier this year–a zebra fish implanted with a fluorescent sea anemone gene. Americans have shown little to no compunction about accepting genetically modified food or genetically modified animals–why start now?
10 Breakthrough Technologies 2024
Every year, we look for promising technologies poised to have a real impact on the world. Here are the advances that we think matter most right now.
Scientists are finding signals of long covid in blood. They could lead to new treatments.
Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.
AI for everything: 10 Breakthrough Technologies 2024
Generative AI tools like ChatGPT reached mass adoption in record time, and reset the course of an entire industry.
OpenAI teases an amazing new generative video model called Sora
The firm is sharing Sora with a small group of safety testers but the rest of us will have to wait to learn more.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.